E233: The Diagnostic Room: The AI Capability Problem Pharma Hasn't Named

In this solo episode of AI For Pharma Growth, Dr Andree Bates explores the AI capability problem pharma has not properly named: training that works in the room, but fails to hold inside the organisation.Dr Andree explains why one-off workshops, generic AI fluency programmes and broad learning platforms are not enough. They may teach people what AI is, what it can do and where it can fail, but they rarely teach the exact workflows, judgement calls and regulatory context people need for their own roles.The episode looks at why AI capability fades over time. Some people leave training and build valuable new workflows, while others forget how to apply what they learned within weeks or months. In pharma, that matters because many AI use cases depend on cognitive, accuracy-based judgement: deciding whether a generated summary faithfully represents a source, whether a claim is substantiated, or whether an output can safely enter a regulated workflow.Dr Andree also explains why generic training can create risk. If usage rises faster than judgement, teams may become more confident with AI without becoming more capable in the workflows where mistakes carry regulatory, compliance or patient safety consequences.The key message is clear: AI capability needs to be maintained, role-specific and grounded in pharma reality. Training once, or training generically, is not a capability plan.Topics CoveredWhy AI training often fails to holdThe difference between awareness and capabilityWhy generic AI fluency is not enoughRole-specific AI workflows in pharmaSkill decay and why 90 days mattersCognitive judgement and regulatory riskWhy confidence can outpace competenceShadow AI and unmanaged tool useWhat real AI capability support must includeThe Pharma AI Enablement InstituteThe Pharma AI Enablement Institute is the structure this episode describes.Foundations everyone starts with, because the regulated reality is common. Then tracks that split by function - every function, from discovery and clinical through regulatory, safety, medical affairs, market access, manufacturing and commercial, up to leadership. Monthly live office hours with Dr Andree Bates. Prompt libraries maintained as the models change. Per-person records a functional sponsor can act on and show an auditor.Hit a problem mid-workflow and your team asks the library in plain language, then lands on the exact video and timestamp where it has already been answered.One price per business unit, banded by size. No per-seat charges — because per-seat pricing is what causes the failure this episode is about.See what the curriculum contains for your function →https://eularis.com/institute/ Read the long-form argument, including what changed in Article 4 of the EU AI Act in July → eularis.com/your-ai-training-worked-thats-the-problem-the-ai-capability-problem-pharma-hasnt-named About the PodcastAI For Pharma Growth is the podcast from Dr Andree Bates, helping pharma, biotech and healthcare organisations understand how AI-based technologies can save time, grow brands and improve company results. The show demystifies AI for biopharma leaders, from start-up biotech through to Big Pharma.Dr. Andree Bates LinkedIn | Facebook | X